Overestimation of Human Immunodeficiency Virus Type 1 Load Caused by the Presence of Cells in Plasma from Plasma Preparation Tubes

• Published in: Journal of Clinical Microbiology Vol. 47; no. 7; pp. 2170 - 2174
• Main Authors: Kran, Anne-Marte Bakken, Jonassen, Tom Øystein, Sannes, Mette, Jakobsen, Kirsti, Lind, Andreas, Mæland, Arild, Holberg-Petersen, Mona
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.07.2009; American Society for Microbiology (ASM)
• Subjects: Biological and medical sciences; Blood Cells - virology; Diagnostic Errors; Fundamental and applied biological sciences. Psychology; HIV-1 - isolation & purification; Human immunodeficiency virus 1; Human viral diseases; Humans; Infectious diseases; Medical sciences; Microbiology; Miscellaneous; Plasma - virology; Specimen Handling - methods; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Viral Load - methods; Virology; Infection; Virus; Immunopathology; Microbiology; HIV-1 virus; Viral disease; Retroviridae; AIDS; Human immunodeficiency virus; Immune deficiency; Lentivirus
• ISSN: 0095-1137; 1098-660X
• DOI: 10.1128/JCM.00519-09

The human immunodeficiency virus type 1 (HIV-1) load is an important marker of disease progression and treatment efficacy in patients with HIV-1 infection. In recent years, an increase in the number of samples with detectable HIV-1 RNA has been reported among patients with previously suppressed viral loads, affecting clinical patient care and leading to repeat measurements of viral load and drug resistance. This rise seems to have coincided with the increased use of plasma preparation tubes (PPTs) for sample collection, and we have aimed to explain why PPTs might yield elevated HIV-1 RNA levels. The impacts of different sample-processing procedures on HIV-1 RNA levels were compared retrospectively. Prospectively, the presence of different cells and cell-associated HIV-1 nucleic acids in paired plasma samples from PPTs centrifuged before (PPT1) and after (PPT2) transportation to the laboratory was compared. A retrospective analysis of 4,049 patient samples with <1,000 HIV-1 RNA copies/ml showed elevated HIV-1 RNA levels in plasma from PPT1 compared with the levels from PPT2 and standard EDTA-containing tubes. Prospective data revealed cell-associated HIV-1 nucleic acids and abundant blood cells in plasma from PPT1 but not from the corresponding PPT2. The levels of HIV-1 RNA correlated with the lymphocyte counts in plasma in PPT1. Cells could be removed by the recentrifugation of PPT1 before analysis. In conclusion, the transportation of PPTs after centrifugation may render cells in the plasma fraction containing cell-associated HIV-1 nucleic acids that contribute significantly to the HIV-1 RNA copy numbers in patients with low viral loads.